Imaging for New Alzheimer’s Drug Aduhelm

We perform imaging used in the diagnosis, treatment and management of Alzheimer’s disease including Amyvid PET CT as well as brain MRI exams with NeuroQuant Analysis. We routinely perform lumbar punctures for CSF analysis to detect the biomarkers associated with Alzheimer’s disease. ERMI also monitors Alzheimer’s treatment medications including Aduhelm, performing MRI examinations with advanced techniques to detect early changes of ARIA (Amyloid Related Imaging Abnomalities).